FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, in particular to the pharmaceutical industry, and describes the gaseous dosage form of the drug for the prevention and treatment of respiratory viral infections. Dosage form is made in the form of a nasal spray, including the active ingredient dioxotetrahydroxytetrahydronaphthalene and excipients: lidocaine hydrochloride, rectified ethyl alcohol, isopropyl myristate.
EFFECT: drug in the form of a spray provides high bioavailability of active substances.
1 cl, 4 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF DIOXOTETRAHYDROXYTETRAHYDRONAPHTHALENE | 2016 |
|
RU2618417C1 |
| MEANS FOR NASAL APPLICATION | 2016 |
|
RU2629330C1 |
| TRANSDERMAL AGENT FOR TREATING AND PREVENTING JOINT AND SOFT TISSUE DISEASES, METHOD FOR PRODUCTION THEREOF AND COMBINED TRANSDERMAL PREPARATION FOR TREATING AND PREVENTING JOINT AND SOFT TISSUE DISEASES | 2013 |
|
RU2582278C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF COLD-RELATED DISEASES AND HERPES SIMPLEX, AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2373950C1 |
| OINTMENT WITH BEE MOTH LARVAE EXTRACT AND PROPOLIS EXTRACT FOR PREVENTION AND INTEGRATED TREATMENT OF VIRAL INFECTION | 2011 |
|
RU2477141C2 |
| APPLICATION OF AMBROXOL FOR TREATMENT OF RHINOVIRUS INFECTIONS | 2006 |
|
RU2409356C2 |
| COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | 2009 |
|
RU2505306C2 |
| GEL WITH OXIMETHYLURACYL, CHLOROHEXIDIN AND LIDOCAINE FOR DIAGNOSTIC AND TREATMENT ENDOURETHRAL PROCEDURES | 2016 |
|
RU2624866C1 |
| ANTIVIRAL AGENT IN LIQUID FORM AND METHOD FOR ITS PREPARATION | 2021 |
|
RU2768656C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL PROPERTIES FOR TREATING EXTERNAL OTITIS | 2013 |
|
RU2528917C1 |
